What if a failed leukemia drug could reduce the risk of Alzheimer’s disease? A team at the University of Kentucky recently led an effort to investigate this hypothesis. Their results were published today in the journal, Human Molecular Genetics.
Members of the public interested in participating in research related to aging and Alzheimer's disease are invited to a town hall-style meeting to be held on Monday, Aug. 19, in Lexington. The meeting, sponsored by the University of Kentucky Sanders-Brown Center on Aging, will take place from 2 to 4 p.m. at the Fayette County Extension Office, 1140 Red Mile Place.
A research team composed of University of Kentucky researchers has published a paper which provides the first direct evidence that activated astrocytes could play a harmful role in Alzheimer's disease. The UK Sanders-Brown Center on Aging has also received significant new National Institutes of Health (NIH) funding to further this line of study.